57 related articles for article (PubMed ID: 30679305)
21. Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: a modelling study.
Fan M; Stephan AJ; Emmert-Fees K; Peters A; Laxy M
Diabetologia; 2023 Sep; 66(9):1693-1704. PubMed ID: 37391625
[TBL] [Abstract][Full Text] [Related]
22. [Level at which control objectives are reached in patients in different population groups with type 2 diabetes].
Herrero A; Pinillos J; Sabio P; Martín JL; Garzón G; Gil Á
Semergen; 2017; 43(8):550-556. PubMed ID: 27889132
[TBL] [Abstract][Full Text] [Related]
23. Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes.
Hermann LS; Ranstam J; Vaaler S; Melander A
Diabetes Obes Metab; 1999 Jul; 1(4):227-32. PubMed ID: 11228758
[TBL] [Abstract][Full Text] [Related]
24. Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry.
Schmieder RE; Gitt AK; Koch C; Bramlage P; Ouarrak T; Tschöpe D;
BMC Endocr Disord; 2015 May; 15():23. PubMed ID: 25934177
[TBL] [Abstract][Full Text] [Related]
25. Real-world effectiveness of treatments for type 2 diabetes, hypercholesterolemia, and hypertension in Canadian routine care - Results from the CardioVascular and metabolic treatment in Canada: Assessment of REal-life therapeutic value (CV-CARE) registry, 12-months results.
Goldenberg R; Bell A; Cheng W; Fils-Aimé N; Burrows M; Blavignac J; Parron E; Barakat M
Diabetes Res Clin Pract; 2020 Dec; 170():108416. PubMed ID: 32891688
[TBL] [Abstract][Full Text] [Related]
26. Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data.
Amadid H; Clemmensen KKB; Vistisen D; Persson F; Jørgensen ME
Cardiovasc Diabetol; 2022 Nov; 21(1):255. PubMed ID: 36419118
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real-world evidence from primary care.
Ling JZJ; Montvida O; Khunti K; Zhang AL; Xue CC; Paul SK
Diabetes Obes Metab; 2021 Jul; 23(7):1518-1531. PubMed ID: 33651456
[TBL] [Abstract][Full Text] [Related]
28. Hypertension control and cardiometabolic risk: a regional perspective.
Thoenes M; Bramlage P; Zhong S; Shang S; Volpe M; Spirk D
Cardiol Res Pract; 2012; 2012():925046. PubMed ID: 22242212
[TBL] [Abstract][Full Text] [Related]
29. Temporal Trend in Young-Onset Type 2 Diabetes-Macrovascular and Mortality Risk: Study of U.K. Primary Care Electronic Medical Records.
Koye DN; Ling J; Dibato J; Khunti K; Montvida O; Paul SK
Diabetes Care; 2020 Sep; 43(9):2208-2216. PubMed ID: 32616608
[TBL] [Abstract][Full Text] [Related]
30. Do improvements in dietary behaviour contribute to cardiovascular risk factor reduction over and above cardio-protective medication in newly diagnosed diabetes patients?
Cooper AJ; Schliemann D; Long GH; Griffin SJ; Simmons RK;
Eur J Clin Nutr; 2014 Oct; 68(10):1113-8. PubMed ID: 24801371
[TBL] [Abstract][Full Text] [Related]
31. Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007-2018.
Mata-Cases M; Vlacho B; Real J; Puig-Treserra R; Bundó M; Franch-Nadal J; Mauricio D
Front Endocrinol (Lausanne); 2021; 12():810757. PubMed ID: 35082758
[TBL] [Abstract][Full Text] [Related]
32. Effect of Health Information Technologies on Cardiovascular Risk Factors among Patients with Diabetes.
Yoshida Y; Boren SA; Soares J; Popescu M; Nielson SD; Koopman RJ; Kennedy DR; Simoes EJ
Curr Diab Rep; 2019 Apr; 19(6):28. PubMed ID: 31030289
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular risk factor control in British adults with diabetes mellitus: Retrospective cohort study.
Collins SÉ; Lethebe BC; Williamson T; McAlister FA
Endocrinol Diabetes Metab; 2020 Apr; 3(2):e00114. PubMed ID: 32318632
[TBL] [Abstract][Full Text] [Related]
34. Glycemic and lipid control in patients with diabetes at time of myocardial infarction.
Lacqua C; Adam H; Zeller M; Vadot L; Bichat F; Maza M; Cottin Y; Boulin M
Ann Pharm Fr; 2024 Apr; ():. PubMed ID: 38685473
[TBL] [Abstract][Full Text] [Related]
35. The danish model for improvement of diabetes care in general practice: impact of automated collection and feedback of patient data.
Schroll H; Christensen RD; Thomsen JL; Andersen M; Friborg S; Søndergaard J
Int J Family Med; 2012; 2012():208123. PubMed ID: 22888424
[TBL] [Abstract][Full Text] [Related]
36. Determinants of cardiovascular disease among type 2 diabetic patients attending diabetic follow-up clinic in Arba Minch general hospital, southern Ethiopia: an unmatched case-control study.
Annose RT; Asefa H; Gezahagn Y; Abebe G; Hailu Zewde T
Ann Med Surg (Lond); 2024 May; 86(5):2467-2473. PubMed ID: 38694275
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the Representativeness of US Centricity Electronic Medical Records With Reports From the Centers for Disease Control and Prevention: Comparative Study on Office Visits and Cardiometabolic Conditions.
Montvida O; Dibato JE; Paul S
JMIR Med Inform; 2020 Jun; 8(6):e17174. PubMed ID: 32490850
[TBL] [Abstract][Full Text] [Related]
38. Third-Line Antidiabetic Therapy Intensification Patterns and Glycaemic Control in Patients with Type 2 Diabetes in the USA: A Real-World Study.
Koye DN; Montvida O; Paul SK
Drugs; 2020 Apr; 80(5):477-487. PubMed ID: 32141024
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular Risk Factor Burden in People With Incident Type 2 Diabetes in the U.S. Receiving Antidiabetic and Cardioprotective Therapies.
Montvida O; Cai X; Paul SK
Diabetes Care; 2019 Apr; 42(4):644-650. PubMed ID: 30679305
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.
Betteridge DJ; Vergès B
Diabetologia; 2005 Dec; 48(12):2477-81. PubMed ID: 16283239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
